Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis

doi:10.3748/wjg.v23.i41.7470

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7342)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

507

WORD

236

HTML

3313

Figures (1-3)

236

Tables (1-4)

265

Sum=4557

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

969

Download

1815

Sum=2784

Nov 7, 2017 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Nov 7, 2017; 23(41): 7470-7477
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7470

Table 4 Changes in portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt in the transjugular intrahepatic portosystemic shunt group

	Before	After	P value
MPV thrombus			< 0.001
Grade 0	0	11
Grade I	7	3
Grade II	11	2
Grade III	2	4
SMV thrombus	5	7	0.731¹
SV thrombus	7	3	0.273¹

¹Determined using Fisher exact test. P value was obtained from a comparison at 24-mo follow-up. Data are numbers of patients. Determined using Mann-Whitney U test. SMA: Superior mesenteric artery; MPV: Main portal vein.

Citation: Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017; 23(41): 7470-7477
URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7470.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7470